Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
MUC17 is an essential small intestinal glycocalyx component that is disrupted in Crohn’s disease
Elena Layunta, Sofia Jäverfelt, Fleur C. van de Koolwijk, Molly Sivertsson, Brendan Dolan, Liisa Arike, Sara I.M. Thulin, Bruce A. Vallance, Thaher Pelaseyed
Elena Layunta, Sofia Jäverfelt, Fleur C. van de Koolwijk, Molly Sivertsson, Brendan Dolan, Liisa Arike, Sara I.M. Thulin, Bruce A. Vallance, Thaher Pelaseyed
View: Text | PDF
Research Article Cell biology Gastroenterology

MUC17 is an essential small intestinal glycocalyx component that is disrupted in Crohn’s disease

  • Text
  • PDF
Abstract

Crohn’s disease (CD) is the chronic inflammation of the terminal ileum and colon triggered by a dysregulated immune response to bacteria, but insights into specific molecular perturbations at the critical bacteria-epithelium interface are limited. Here, we report that the membrane mucin MUC17 protected small intestinal enterocytes against commensal and pathogenic bacteria. In noninflamed CD ileum, reduced MUC17 levels and a compromised glycocalyx barrier allowed recurrent bacterial contact with enterocytes. Muc17 deletion in mice rendered the small intestine particularly prone to atypical bacterial infection while maintaining resistance to colitis. The loss of Muc17 resulted in spontaneous deterioration of epithelial homeostasis and in the extraintestinal translocation of bacteria. Finally, Muc17-deficient mice harbored specific small intestinal bacterial taxa observed in patients with CD. Our findings highlight MUC17 as an essential region-specific line of defense in the small intestine with relevance for early epithelial defects in CD.

Authors

Elena Layunta, Sofia Jäverfelt, Fleur C. van de Koolwijk, Molly Sivertsson, Brendan Dolan, Liisa Arike, Sara I.M. Thulin, Bruce A. Vallance, Thaher Pelaseyed

×

Figure 1

Reduced surface levels of MUC17 and a permeable glycocalyx in the noninflamed ileum of patients with Crohn’s disease.

Options: View larger image (or click on image) Download as PowerPoint
Reduced surface levels of MUC17 and a permeable glycocalyx in the noninf...
(A) Cartoon of human and mouse MUC17 and MUC13. (B) Membrane mucin mRNA transcripts at single-cell resolution in human small intestinal epithelial cells. (C) Membrane mucin mRNA transcripts in human colonic epithelial cells. Row maximum and minimum represent relative expression of each gene among cell types. EC, enterocyte; ISC, intestinal stem cell; TA, transit amplifying; Sec. Prog., secretory progenitor; Goblet, goblet cell; S/G2, S and G2 phase; M, M phase. (D) Immunohistochemistry of MUC17 (green), Ezrin (magenta), and DNA (cyan) in sections of noninflamed ileal biopsies from non-IBD and CD patients, alongside semiquantitative analysis of MUC17 levels in the brush border. Each channel is shown in grayscale. Yellow arrow points to the brush border. Scale bar, 100 μm. Insets, 30 µm. n = 16 for non-IBD, n = 9 for CD. (E) Immunohistochemistry of MUC13 (green), Ezrin (magenta), and DNA (cyan) in noninflamed ileal biopsies from non-IBD control and CD patients, alongside semiquantitative analysis of MUC13 in the brush border. Each channel is shown in grayscale. Yellow arrow points to the brush border. Scale bar, 100 μm. Insets, 30 µm. n = 16 for non-IBD, n = 9 for CD. (F) Time-lapse glycocalyx permeability assay in noninflamed ileal biopsies from non-IBD and CD patients, stained with CellMask and incubated with E. coliGFP+ tracked over the course of 6 minutes. Yellow arrows show overlap between E. coliGFP+ and CellMask. Dashed white line marks the brush border. Magnifications are labeled with numbers. Scale bar, 10 μm. Insets, 8 µm. Pseudocolor scale indicates time points during tracking bacteria. Bar graph depicts frequency of E. coliGFP+ attached to the brush border. n = 7 for non-IBD, n = 8 for CD. Data are means ± SD. Significance was determined by unpaired 2-tailed t test (D–F). Estimation plot shows the difference between CD and non-IBD means with a 95% confidence interval.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts